17.3 EFFECT OF CANNABIDIOL ON SYMPTOMS, DISTRESS AND NEUROPHYSIOLOGICAL ABNORMALITIES IN CLINICAL HIGH-RISK FOR PSYCHOSIS PATIENTS: A PLACEBO-CONTROLLED STUDY

BACKGROUND: There has been growing interest in the therapeutic potential of Cannabidiol (CBD) stemming from independent evidence that CBD has antipsychotic and anxiolytic properties in patients with mental health disorders. CBD has been found to be non-inferior to antipsychotic medication in a 4-wee...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharyya, Sagnik, Wilson, Robin, Allen, Paul, Bossong, Matthijs, Appiah-Kusi, Elizabeth, McGuire, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888230/
http://dx.doi.org/10.1093/schbul/sby014.067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888230/
http://dx.doi.org/10.1093/schbul/sby014.067

Ejemplares similares